Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade

被引：0

作者：

Chen, Shuming ^{[1
]}

Soni, Abha ^{[1
]}

McMiller, Tracee ^{[1
]}

Sidhom, John-William ^{[1
]}

Succaria, Farah ^{[1
]}

Berger, Alan ^{[1
]}

Hooper, Jody ^{[1
]}

Pardoll, Drew ^{[1
]}

Lipson, Evan ^{[1
]}

Taube, Janis ^{[1
]}

Topalian, Suzanne ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O11

引用

页数：1

共 1 条

[1] Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab [J].

Topalian, Suzanne L. ;

Hodi, F. Stephen ;

Brahmer, Julie R. ;

Gettinger, Scott N. ;

Smith, David C. ;

McDermott, David F. ;

Powderly, John D. ;

Sosman, Jeffrey A. ;

Atkins, Michael B. ;

Leming, Philip D. ;

Spigel, David R. ;

Antonia, Scott J. ;

Drilon, Alexander ;

Wolchok, Jedd D. ;

Carvajal, Richard D. ;

McHenry, M. Brent ;

Hosein, Fareeda ;

Harbison, Christopher T. ;

Grosso, Joseph F. ;

Sznol, Mario .

JAMA ONCOLOGY, 2019, 5 (10) :1411-1420

← 1 →